Literature DB >> 25059698

Transcranial sonography of the substantia nigra: digital image analysis.

D Skoloudík1, M Jelínková2, J Blahuta3, P Cermák3, T Soukup3, P Bártová4, K Langová5, R Herzig6.   

Abstract

BACKGROUND AND
PURPOSE: Increased echogenicity of the substantia nigra is a typical transcranial sonography finding in Parkinson disease. Experimental software for digital analysis of the echogenic substantia nigra area has been developed. The aim of this study was to compare the evaluation of substantia nigra echogenicity by using digital analysis with a manual measurement in patients with Parkinson disease and healthy volunteers.
MATERIALS AND METHODS: One hundred thirteen healthy volunteers were enrolled in the derivation cohort, and 50 healthy volunteers and 30 patients with Parkinson disease, in the validation cohort. The substantia nigra was imaged from the right and left temporal bone window by using transcranial sonography. All subjects were examined twice by using different sonographic machines by an experienced sonographer. DICOM images of the substantia nigra were encoded; then, digital analysis and manual measurement of the substantia nigra were performed. The 90th percentile of the derivation cohort values was used as a cut-point for the evaluation of the hyperechogenic substantia nigra in the validation cohort. The Spearman coefficient was used for assessment of the correlation between both measurements. The Cohen κ coefficient was used for the assessment of the correlation between both measurements and Parkinson disease diagnosis.
RESULTS: The Spearman coefficient between measurements by using different machines was 0.686 for digital analysis and 0.721 for manual measurement (P < .0001). Hyperechogenic substantia nigra was detected in the same 26 (86.7%) patients with Parkinson disease by using both measurements. Cohen κ coefficients for digital analysis and manual measurement were 0.787 and 0.762, respectively (P < .0001).
CONCLUSIONS: The present study showed comparable results when measuring the substantia nigra features conventionally and by using the developed software.
© 2014 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2014        PMID: 25059698      PMCID: PMC7965312          DOI: 10.3174/ajnr.A4049

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  30 in total

1.  Predictive value of transcranial sonography in the diagnosis of Parkinson's disease.

Authors:  Jürgen Prestel; Katherine J Schweitzer; Anne Hofer; Thomas Gasser; Daniela Berg
Journal:  Mov Disord       Date:  2006-10       Impact factor: 10.338

2.  When did Ray Kennedy's Parkinson's disease begin?

Authors:  A J Lees
Journal:  Mov Disord       Date:  1992       Impact factor: 10.338

3.  Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity.

Authors:  Ruediger Hilker; Katherine Schweitzer; Silke Coburger; Mehran Ghaemi; Simon Weisenbach; Andreas H Jacobs; Jobst Rudolf; Karl Herholz; Wolf-Dieter Heiss
Journal:  Arch Neurol       Date:  2005-03

4.  Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy.

Authors:  D Berg; B Jabs; U Merschdorf; H Beckmann; G Becker
Journal:  Biol Psychiatry       Date:  2001-09-15       Impact factor: 13.382

5.  In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage.

Authors:  Luigi Zecca; Daniela Berg; Thomas Arzberger; Petra Ruprecht; Wolf D Rausch; Massimo Musicco; Davide Tampellini; Peter Riederer; Manfred Gerlach; Georg Becker
Journal:  Mov Disord       Date:  2005-10       Impact factor: 10.338

6.  Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease.

Authors:  Petra Ruprecht-Dörfler; Daniela Berg; Oliver Tucha; Peter Benz; Michael Meier-Meitinger; Gesine L Alders; Klaus W Lange; Georg Becker
Journal:  Neuroimage       Date:  2003-02       Impact factor: 6.556

Review 7.  Method and validity of transcranial sonography in movement disorders.

Authors:  David Skoloudík; Uwe Walter
Journal:  Int Rev Neurobiol       Date:  2010       Impact factor: 3.230

8.  Assessment of the cerebral venous system from the transcondylar ultrasound window using virtual navigator technology and MRI.

Authors:  Maria Marcella Laganà; Leonardo Forzoni; Stefano Viotti; Stefano De Beni; Giuseppe Baselli; Pietro Cecconi
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2011

9.  Parkinson's Disease Society Brain Bank, London: overview and research.

Authors:  S E Daniel; A J Lees
Journal:  J Neural Transm Suppl       Date:  1993

10.  Hyperechogenicity of the substantia nigra in Parkinson's disease.

Authors:  Pavel Ressner; David Skoloudík; Petr Hlustík; Petr Kanovský
Journal:  J Neuroimaging       Date:  2007-04       Impact factor: 2.486

View more
  7 in total

Review 1.  Developments in the role of transcranial sonography for the differential diagnosis of parkinsonism.

Authors:  Andrea Pilotto; Rezzak Yilmaz; Daniela Berg
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

Review 2.  [Helpful instrumental examinations in idiopathic Parkinson's disease].

Authors:  U Walter; H Zach; I Liepelt-Scarfone; W Maetzler
Journal:  Nervenarzt       Date:  2017-04       Impact factor: 1.214

Review 3.  Biomarkers for Parkinson's Disease: Recent Advancement.

Authors:  Sharvari Lotankar; Kedar S Prabhavalkar; Lokesh K Bhatt
Journal:  Neurosci Bull       Date:  2017-09-21       Impact factor: 5.203

4.  The measuring of substantia nigra hyperechogenicity in an Italian cohort of Parkinson disease patients: a case/control study (NOBIS Study).

Authors:  Patrizio Prati; A Bignamini; L Coppo; A Naldi; C Comi; R Cantello; G Gusmaroli; U Walter
Journal:  J Neural Transm (Vienna)       Date:  2017-04-27       Impact factor: 3.575

5.  Value of ultrasound fusion imaging in detecting vascular cerebral white matter pathology.

Authors:  Cornelia Brunner; Stephan Joachim Schreiber; Martin Bokemeyer; Gerhard Ransmayr; Walter Struhal; Elisabeth Daniela Olbert; Naela Alhani; Milan Rastislav Vosko
Journal:  Ultrasound J       Date:  2022-06-17

Review 6.  Parkinson's Disease: Biomarkers, Treatment, and Risk Factors.

Authors:  Fatemeh N Emamzadeh; Andrei Surguchov
Journal:  Front Neurosci       Date:  2018-08-30       Impact factor: 4.677

Review 7.  Emerging Therapeutic Strategies for Parkinson's Disease and Future Prospects: A 2021 Update.

Authors:  Noha A Gouda; Ahmed Elkamhawy; Jungsook Cho
Journal:  Biomedicines       Date:  2022-02-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.